halimi_bw-4.jpg
 

Hoji Alimi

FOUNDER, CHAIRMAN AND CEO

  • 20 years of experience in the global healthcare industry

  • Chairman, CEO Ruthigen, Inc.

  • IPO experience, including raising $170M in capital

  • FDA and CE approvals of multiple drugs and devices


bwatson_bw-3.jpg
 
 

Bill Watson

CO-FOUNDER, VP OF BUSINESS DEVELOPMENT AND SALES

  • Vice President, Sales and Business Development

  • Investment Banker completed over $400M in transactions

  • Director of National Investment Bankers Association


btchekanova_bw-2.jpg
 

Bani tchekanova

VICE PRESIDENT REGULATORY AFFAIRS

  • Extensive experience in the pharmaceutical industry, research and development for marketed and in development products, global Regulatory affairs and clinical research.

  • Has held positions in industry as Director of Clinical Operations at Artemis, Director of Regulatory Affairs at Merck Serono, Head of International Labeling Operation at Boehringer Ingelheim and Therapeutic Lead in oncology at Abbott.

  • Extensive scientific, drug development and regulatory experience.

  • Earned a Ph.D. in healthcare administration, MS in clinical laboratory sciences, and two bachelor degrees in biology and chemistry.


sharish_bw-2.jpg
 

Sameer Harish

DIRECTOR OF FINANCE

  • Served as Chief Financial Officer of Ruthigen, Inc.

  • Buy-side and Sell-side equity research analyst covering medical devices and diagnostics sectors with Symmetry Capital, Needham & Co., and ThinkEquity

  • Held research positions at Guidant (now Abbott Laboratories) and Synteni (acquired by Incyte Corporation)